Michael Amdahl - Concepedia

Concepedia

Author

Michael Amdahl

Also Known As

M Amdahl, M. Amdahl, M. J. Amdahl, M. Wolf, M.J. Amdahl, Michael Amdahl, Michael J Amdahl, S. Nikitin

25

Publications

1.8K

Citations

11

H-Index

9

Concepts

All Affiliations

Abbott Fund Abbott (United Kingdom)University Medical Center Groningen University of Groningen Heidelberg University

MA

About

Michael Amdahl is an author at Abbott Fund specializing in medicine, chronic kidney disease, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	791
2	Diabetes	1	1	686
3	Nephrology	1	1	55
4	Pharmacology	1	1	686
5	Hemodialysis	1	1	55

Michael Amdahl

×

11

Publications

1.8K

Citations

11

H-Index

	Year	Citations
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl, The Lancet Renal FunctionVital StudyDiabetesPharmacologyType 2	2010	686
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism Stuart M. Sprague, Francisco Llach, Michael Amdahl, Kidney International Parathyroid DiseaseParathyroid GlandParathyroid HormoneParicalcitol Versus Calcitriol	2003	384
Performance of hemodialysis with novel medium cut-off dialyzers Alexander H. Kirsch, Raphael Lyko, Lars‐Göran Nilsson, Nephrology Dialysis Transplantation	2016	226
Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings D. Dobrez, Ângelo do Carmo da Silva Mathes, Michael Amdahl, Nephrology Dialysis Transplantation	2004	114
Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study Markus Ketteler, Kévin Martin, Myles Wolf, Nephrology Dialysis Transplantation	2012	99
Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis Larry A. Greenbaum, Nadine Benador, Stuart L. Goldstein, American Journal of Kidney Diseases HemodialysisUrologySecondary HyperparathyroidismMedicineIntravenous Paricalcitol	2007	55
Differential Effects of Paricalcitol and Calcitriol on Intestinal Calcium Absorption in Hemodialysis Patients Richard Lund, Dennis L. Andress, Michael Amdahl, American Journal of Nephrology	2009	52
Paricalcitol dosing according to body weight or severity of hyperparathyroidism: A double-blind, multicenter, randomized study Kévin Martin, Jill S. Lindberg, Carol Taccetta, American Journal of Kidney Diseases HypertensionParathyroid HormoneParathyroid DiseaseParathyroid GlandBody Weight	2001	50
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics Hiddo J.L. Heerspink, Rajiv Agarwal, Daniel W. Coyne, American Journal of Nephrology	2009	38
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study Daniel W. Coyne, D.L. Andress, Michael Amdahl, Nephrology Dialysis Transplantation	2013	38

Page 1